WNT9A — Wnt Family Member 9A
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">WNT9A — Wnt Family Member 9A</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>WNT9A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>WNT9A — Wnt Family Member 9A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=WNT9A" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
WNT9A (Wnt Family Member 9A) is a secreted signaling protein belonging to the Wnt family that plays essential roles in embryonic development, tissue patterning, and adult tissue homeostasis[@wntfamily2023]. Like other Wnt proteins, WNT9A activates canonical Wnt/β-catenin signaling by binding to Frizzled receptors and LRP co-receptors, leading to β-catenin stabilization and translocation to the nucleus where it activates TCF/LEF target genes[@wntneuro2022].
WNT9A is particularly important for kidney development (nephrogenesis) and has been implicated in neural progenitor cell regulation, synaptic function, and cancer progression[@wnt9adev2018]. Altered WNT9A signaling has been reported in Alzheimer's disease and other neurodegenerative conditions, where Wnt pathway dysregulation contributes to disease pathogenesis[@wntbeta2021].
Molecular Biology
Gene and Protein Structure
...WNT9A — Wnt Family Member 9A
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">WNT9A — Wnt Family Member 9A</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>WNT9A</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>WNT9A — Wnt Family Member 9A</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=WNT9A" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
WNT9A (Wnt Family Member 9A) is a secreted signaling protein belonging to the Wnt family that plays essential roles in embryonic development, tissue patterning, and adult tissue homeostasis[@wntfamily2023]. Like other Wnt proteins, WNT9A activates canonical Wnt/β-catenin signaling by binding to Frizzled receptors and LRP co-receptors, leading to β-catenin stabilization and translocation to the nucleus where it activates TCF/LEF target genes[@wntneuro2022].
WNT9A is particularly important for kidney development (nephrogenesis) and has been implicated in neural progenitor cell regulation, synaptic function, and cancer progression[@wnt9adev2018]. Altered WNT9A signaling has been reported in Alzheimer's disease and other neurodegenerative conditions, where Wnt pathway dysregulation contributes to disease pathogenesis[@wntbeta2021].
Molecular Biology
Gene and Protein Structure
The WNT9A gene is located on chromosome 1q42.13 and encodes a 355-amino acid secreted protein[@wntfamily2023]. The protein contains:
- Signal peptide: Directs secretion from producing cells
- Wnt domain: Conserved cysteine-rich domain with 24 cysteine residues
- Glycosylation sites: N-linked glycosylation affecting protein stability
- Lipid modification: C-terminal palmitoleoylation required for secretion
Wnt Signaling Pathways
WNT9A primarily activates the canonical Wnt/β-catenin pathway[@wntneuro2022]:
Canonical Pathway Activation
WNT9A binds to Frizzled (FZD) receptor and LRP5/6 co-receptor
Prevents destruction complex (Axin/APC/GSK3β) from degrading β-catenin
β-catenin accumulates and translocates to the nucleus
Forms complex with TCF/LEF transcription factors
Activates target genes involved in proliferation, differentiation, and survivalNon-canonical Pathways
WNT9A can also activate non-canonical pathways:
- Wnt/PCP pathway: Through FZD receptors without LRP
- Wnt/Ca²⁺ pathway: Calcium release and PKC activation
Biological Function
Kidney Development
WNT9A is a critical regulator of nephron development[@wnt9adev2018]:
- Ureteric bud branching: Directs branching morphogenesis of the ureteric bud
- Mesenchymal-to-epithelial transition: Converts metanephric mesenchyme to epithelial nephron precursors
- Nephron patterning: Establishes proximal-distal tubule identity
- Glomerulogenesis: Affects podocyte differentiation
Neural Progenitor Cells
WNT9A regulates neural progenitor cell behavior[@neuralprogenitor2019]:
- Self-renewal: Maintains progenitor cell pools
- Proliferation: Promotes cell division in SVZ and SGZ
- Differentiation: Influences neuronal and glial lineage decisions
- Migration: Guides neuroblast migration in the rostral migratory stream
Synaptic Function
WNT9A is involved in synaptic development[@synapse2015]:
- Synaptogenesis: Promotes excitatory synapse formation
- Presynaptic assembly: Induces presynaptic vesicle proteins
- Postsynaptic differentiation: Affects PSD95 clustering
- Synaptic plasticity: Modulates LTP and LTD
Stem Cell Biology
WNT9A affects stem cell populations[@stemcell2017]:
- Embryonic stem cells: Maintains pluripotency
- Intestinal stem cells: Regulates crypt stem cell proliferation
- Hair follicle stem cells: Controls cycling
- Neural stem cells: Affects adult neurogenesis
Expression Patterns
Developmental Expression
During embryonic development, WNT9A is expressed in[@wnt9adev2018]:
- Kidney: Metanephric blastema, developing nephrons
- Spinal cord: Motor neuron domains
- Brain: Developing cortex and hippocampus
- Lung: Bronchial epithelium
- Gastrointestinal tract: Intestinal crypts
Adult Expression
In adult tissues, WNT9A expression is maintained in[@neurogenesis2018]:
- Brain: Subventricular zone, dentate gyrus
- Intestine: Intestinal crypt base (stem cell niche)
- Kidney: Tubular epithelium
- Lung: Alveolar epithelium
- Hair follicle: Bulge region (stem cell compartment)
Role in Neurodegeneration
Alzheimer's Disease
WNT9A and canonical Wnt signaling are prominently implicated in Alzheimer's disease[@wntbeta2021]:
- β-catenin reduction: WNT9A signaling is reduced in AD brains
- Amyloid-beta effects: Aβ interferes with Wnt receptor function
- Tau pathology: Wnt/β-catenin regulates tau phosphorylation through GSK3β
- Synaptic dysfunction: WNT9A is important for synaptic maintenance
- Neurogenesis: Adult hippocampal neurogenesis is impaired in AD
Research shows specific alterations:
- Reduced WNT9A expression in AD temporal cortex
- Impaired β-catenin nuclear translocation
- Altered Frizzled receptor expression
Parkinson's Disease
WNT9A may play roles in Parkinson's disease[@wntneuro2022]:
- Dopaminergic neuroprotection: Wnt signaling supports dopaminergic neuron survival
- Alpha-synuclein: Interaction with aggregation pathways
- Mitochondrial function: Wnt signaling affects mitochondrial biogenesis
- Neuroinflammation: Modulates microglial activation
Neuroinflammation
WNT9A modulates neuroinflammatory processes[@neuroinflammation2019]:
- Microglial phenotype: Wnt signaling regulates M1/M2 polarization
- Cytokine production: Affects TNF-α, IL-1β, IL-6 production
- Blood-brain barrier: Maintains BBB integrity
- Peripheral immunity: Modulates T-cell CNS infiltration
Neural Stem Cells
WNT9A is critical for adult neural stem cell function[@neurogenesis2018]:
- SVZ function: Maintains subventricular zone neural stem cells
- Hippocampal neurogenesis: Regulates dentate gyrus progenitors
- Olfactory neurogenesis: Affects olfactory bulb neurogenesis
- Regeneration potential: May enable endogenous repair mechanisms
Disease Associations
Kidney Disorders
WNT9A variants are associated with[@renal2020]:
- Renal hypoplasia: Incomplete kidney development
- Congenital anomalies: CAKUT (Congenital Anomalies of the Kidney and Urinary Tract)
- Polycystic kidney disease: Altered Wnt signaling in cystogenesis
- Renal fibrosis: Associated with chronic kidney disease
Neural Tube Defects
WNT9A dysregulation contributes to:
- Spina bifida: Due to disrupted neural tube closure
- Anencephaly: Brain tissue maldevelopment
- Chiari malformation: Cerebellar tonsil herniation
Cancer
WNT9A is frequently dysregulated in cancers[@cancer2021]:
- Breast cancer: Overexpression associated with poor prognosis
- Colorectal cancer: Promotes tumor progression
- Ovarian cancer: Linked to metastasis
- Hepatocellular carcinoma: Enhanced stemness
Neurological Disorders
WNT9A is implicated in:
- Alzheimer's disease: Reduced signaling
- Parkinson's disease: Possible dopaminergic effects
- Mood disorders: Altered Wnt signaling in depression
- Schizophrenia: Associated with neurodevelopmental hypotheses
Therapeutic Implications
Targeting Wnt Signaling
Therapeutic approaches targeting WNT9A and downstream pathways include[@wntneuro2022]:
- Wnt pathway activators: Restore Wnt signaling in neurodegeneration
- Wnt secretory modulators: Control WNT9A availability
- Frizzled receptor agonists: Enhance receptor activation
- β-catenin stabilizers: Promote downstream signaling
Clinical Applications
WNT9A-based therapies may benefit:
- Alzheimer's disease: Neuroprotection, synaptic maintenance
- Parkinson's disease: Dopaminergic neuron support
- Chronic kidney disease: Renal regeneration
- Cancer: Targeting WNT9A-overexpressing tumors
Challenges
- Pathway complexity: Multiple downstream effectors
- Tissue specificity: Different effects in different contexts
- Developmental roles: Critical functions in development
- Bidirectional effects: Both hyper- and hypo-signaling problematic
Genetic Variation
WNT9A polymorphisms have been associated with:
- Renal developmental disorders: Susceptibility variants
- Neural tube defects: Risk alleles
- Cancer prognosis: Expression quantitative trait loci
- Neurodegenerative disease: Possible associations
See Also
- [WNT Signaling Pathway](/mechanisms/wnt-signaling-pathway-neurodegeneration)
- [Wnt/β-Catenin Signaling Pathway](/mechanisms/wnt-beta-catenin-signaling-pathway)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Neural Stem Cells](/entities/neural-stem-cells)
- [Subventricular Zone](/brain-regions/subventricular-zone)
- [Hippocampus](/brain-regions/hippocampus)
References
[Nusse et al., Wnt proteins: from development to regeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/36868256/)
[Chen et al., Wnt signaling in neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35298247/)
[Marquer et al., Wnt/beta-catenin signaling in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34224689/)
[Karkkainen et al., Wnt9a is required for kidney development (2018)](https://pubmed.ncbi.nlm.nih.gov/29456723/)
[Choe et al., Wnt signaling in neural progenitor cell regulation (2019)](https://pubmed.ncbi.nlm.nih.gov/31193861/)
[Devenport, Planar cell polarity in development and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32219408/)
[Wang et al., Wnt signaling in synaptic formation and function (2015)](https://pubmed.ncbi.nlm.nih.gov/26217180/)
[Sato et al., Wnt signaling in stem cell biology (2017)](https://pubmed.ncbi.nlm.nih.gov/28653654/)
[Yu et al., Wnt9a and renal development (2020)](https://pubmed.ncbi.nlm.nih.gov/32044293/)
[Song et al., Wnt signaling in adult neurogenesis (2018)](https://pubmed.ncbi.nlm.nih.gov/29429945/)
[He et al., Wnt signaling and cilia in development (2019)](https://pubmed.ncbi.nlm.nih.gov/31006324/)
[Zhao et al., Wnt9a dysregulation in cancer (2021)](https://pubmed.ncbi.nlm.nih.gov/33846623/)
[Liu et al., Wnt signaling alterations in Alzheimer's disease brain (2022)](https://pubmed.ncbi.nlm.nih.gov/35065512/)
[Halleskog et al., Wnt signaling in neuroinflammation (2019)](https://pubmed.ncbi.nlm.nih.gov/30606247/)